Resource and infrastructure challenges on the RESIST-2 Trial: an implementation study of drug resistance genotype-based algorithmic ART switches in HIV-2-infected adults in Senegal.

Trials · 2021 · PMC8683814 · PMID 34922614

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

With return to routine medical care only becoming possible in December 2020, the opportunity cost of pandemic-related shutdowns is likely to be significant both to research as well as to the patients who stand to benefit from this work.

also in 1,824 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.